H19 deficiency protects the mice from bile duct ligation (BDL)-induced cholangiocyte proliferation and liver fibrosis via inhibiting bile acid-induced expression and activation of sphingosine 1-phosphate receptor 2 (S1PR2) [17]. The gene discussed is S1PR2; the disease is Hepatic fibrosis.